Mid Atlantic Financial Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$471K Buy
1,263
+136
+12% +$51.7K 0.03% 470
2021
Q2
$430K Buy
1,127
+72
+7% +$27.5K 0.03% 526
2021
Q1
$379K Buy
1,055
+128
+14% +$41.2K 0.03% 531
2020
Q4
$298K Buy
927
+2
+0.2% +$614 0.02% 578
2020
Q3
$298K Buy
925
+97
+12% +$26.1K 0.03% 516
2020
Q2
$218K Buy
+828
New +$221K 0.02% 602
2020
Q1
Sell
-829
Closed -$251K 707
2019
Q4
$251K Sell
829
-14
-2% -$3.85K 0.02% 576
2019
Q3
$202K Sell
843
-192
-19% -$52.6K 0.02% 618
2019
Q2
$292K Buy
+1,035
New +$283K 0.03% 529

Other funds holding ELV

Mid Atlantic Financial Management's ELV Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its Elevance Health (ELV) stake by 12% in Q3 2021, buying an estimated $51.7K and bringing the position to 1,263 shares worth $471K. The position accounts for 0.03% of the portfolio, ranked #470.

Mid Atlantic Financial Management first reported a position in ELV in Q2 2019 and has held it in 9 quarters since. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Mid Atlantic Financial Management held 1,263 shares of Elevance Health worth $471K as of Q3 2021.
  • Mid Atlantic Financial Management bought 136 Elevance Health shares in Q3 2021, an estimated $51.7K.
  • Elevance Health made up 0.03% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #470 holding.
  • Mid Atlantic Financial Management first reported a position in Elevance Health in Q2 2019 and has held it in 9 quarters since.
  • 1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.